Back to TSHA

Octagon Capital Advisors LP → TSHA

Octagon Capital Advisors LP TSHA Position History

Taysha Gene Therapies, Inc. • Healthcare

Quarters held
4
Latest value
$47.2M
Q3 2026
Peak value
$66M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$48.7M
Q1 2026$39.6M
Q2 2026$66M
Q3 2026$47.2M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$47.2M9.69M——
Q2 2026$66M9.69M——
Q1 2026$39.6M8.86M——
Q4 2025$48.7M8.86M——

Other funds holding TSHA

Other Octagon Capital Advisors LP positions

DNTH

DIANTHUS THERAPEUTICS INC

$179.5M
DNTH

DIANTHUS THERAPEUTICS INC

$163.4M
DNTH

DIANTHUS THERAPEUTICS INC

$148.5M
DFTX

DEFINIUM THERAPEUTICS INC

$138.8M
AAVXF

ABIVAX SA

$132.3M
AAVXF

ABIVAX SA

$102M
DNTH

DIANTHUS THERAPEUTICS INC

$99.6M
AAVXF

ABIVAX SA

$98.3M